Monte Rosa Therapeutics Overview

Monte Rosa Therapeutics Profit Margin

Profitability ratio analysis for GLUE.

Quarterly Profit Margin

-1057.08%

↓ 2014.83% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-302.69%

↓ 7945.76% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin